287 results found. Viewing page 4 of 58.
Go to page . . .
Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...
Continue Reading...
Despite the overall decreased use of asbestos nationwide, mesothelioma deaths among women still managed to increase by 25% over the past two decades. This according to death record statistics published by the Centers for Disease Control and ...
Continue Reading...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...
Continue Reading...
A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...
Continue Reading...
Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...
Continue Reading...
287 results found. Viewing page 4 of 58.
Go to page . . .